Solstice Neurosciences, LLC clinical trials
Acquired by Supernus Pharmaceuticals, Inc., Jun 9, 2020 · source ↗
The registry lists 3 studies whose lead sponsor is Solstice Neurosciences, LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 27, 2026.
Before and after it joined Supernus Pharmaceuticals, Inc.
- First submitted before Solstice Neurosciences, LLC became part of Supernus Pharmaceuticals, Inc.
- 1
- First submitted after Solstice Neurosciences, LLC became part of Supernus Pharmaceuticals, Inc.
- 2
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC3 studies
Something wrong with this grouping? Tell us on the Supernus Pharmaceuticals, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Supernus Pharmaceuticals, Inc. studies →
- Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb SpasticityTerminatedNCT04815967Phase 2/3
Sponsor listed in the registry: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC · First submitted after Solstice Neurosciences, LLC became part of Supernus Pharmaceuticals, Inc.
- Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb SpasticityTerminatedNCT04099667Phase 2/3
Sponsor listed in the registry: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC · First submitted before Solstice Neurosciences, LLC became part of Supernus Pharmaceuticals, Inc.
- Efficacy and Safety Study of MYOBLOC in the Treatment of Sialorrhea in Pediatric SubjectsWithdrawnNCT05097079Phase 3
Sponsor listed in the registry: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC · First submitted after Solstice Neurosciences, LLC became part of Supernus Pharmaceuticals, Inc.